Agile Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.48 | -$0.48 | -$0.48 |
| Q2 2024 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q3 2024 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q4 2024 | 1 | $0.10 | $0.10 | $0.10 |
| Q1 2025 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2025 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2025 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2025 | 0 | $0.00 | $0.00 | $0.00 |
Agile Therapeutics, Inc. Earnings Date And Information
Agile Therapeutics, Inc. last posted its earnings results on Wednesday, May 15th, 2024. The company reported $-0.63 earnings per share for the quarter, missing analysts' consensus estimates of $-0.51 by $0.12. The company had revenue of 5.58 M for the quarter and had revenue of 19.59 M for the year. Agile Therapeutics, Inc. has generated $-7 earnings per share over the last year ($-6.71 diluted earnings per share) and currently has a price-to-earnings ratio of -0.65. Agile Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
Agile Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/12/2024 | Q2 2024 | -$1.73 | $7.50 M | $5.58 M | ||
| 05/15/2024 | Q1 2024 | -$0.51 | $0.28 | 0.79 | $5.72 M | |
| 03/28/2024 | Q4 2023 | -$0.92 | -$1.51 | -0.59 | $3.61 M | |
| 11/09/2023 | Q3 2023 | -$1.84 | -$0.27 | 1.57 | $6.77 M | $6.66 M |
| 08/09/2023 | Q2 2023 | -$3.48 | -$2.15 | 1.33 | $4.63 M | $5.50 M |
| 05/11/2023 | Q1 2023 | -$7.50 | -$3.96 | 3.54 | $3.81 M | |
| 03/22/2023 | Q4 2022 | -$16.10 | $4.00 M | |||
| 11/07/2022 | Q3 2022 | -$15.00 | -$29.80 | -14.8 | $2.33 M | $3.00 M |
| 08/11/2022 | Q2 2022 | -$3.70 | -$135.46 | -131.76 | $1.98 M | $2.13 M |
| 05/12/2022 | Q1 2022 | -$0.15 | -$188.90 | -188.75 | $1.76 M | |
| 03/30/2022 | Q4 2021 | -$400.22 | $1.51 M | |||
| 11/02/2021 | Q3 2021 | -$380.00 | -$360.01 | 19.99 | $1.46 M | $1.29 M |
| 07/26/2021 | Q2 2021 | -$420.00 | -$397.71 | 22.29 | $1.13 M | $1.19 M |
| 05/04/2021 | Q1 2021 | -$440.00 | -$390.94 | 49.06 | $116,000 | |
| 03/01/2021 | Q4 2020 | -$460.00 | -$402.98 | 57.02 | $749,000 | |
| 11/12/2020 | Q3 2020 | -$360.00 | -$360.00 | 0 | $0 | |
| 08/11/2020 | Q2 2020 | -$260.00 | -$248.25 | 11.75 | $0 | |
| 05/05/2020 | Q1 2020 | -$180.00 | -$205.68 | -25.68 | $0 | |
| 02/20/2020 | Q4 2019 | -$160.00 | -$192.49 | -32.49 | $0 | |
| 10/28/2019 | Q3 2019 | -$160.00 | -$165.35 | -5.35 | $0 |
Agile Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Agile Therapeutics, Inc.'s earnings date?
Agile Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
How can I listen to Agile Therapeutics, Inc.'s earnings conference call?
The conference call for Agile Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Agile Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Agile Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Agile Therapeutics, Inc. generate each year?
Agile Therapeutics, Inc. (:AGRX) has a recorded annual revenue of $19.59 M.
-
How much profit does Agile Therapeutics, Inc. generate each year?
Agile Therapeutics, Inc. (:AGRX) has a recorded net income of $19.59 M. Agile Therapeutics, Inc. has generated $-6.71 earnings per share over the last four quarters.
-
What is Agile Therapeutics, Inc.'s price-to-earnings ratio?
Agile Therapeutics, Inc. (:AGRX) has a price-to-earnings ratio of -0.65 and price/earnings-to-growth ratio is -0.06.
